Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets
The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.
- An overview of the regional and global markets for Autism Spectrum Disorder (ASD) therapies and diagnostics.
- Analyses of global market trends, with data from 2013, 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- An overview of ASDs including types, epidemiology, symptoms, and causes and pathophysiology.
- Coverage of approved therapies and tolerated off-label alternative treatments for ASD.
- In-depth analysis of the ASD therapies market dynamics, specifically growth drivers, inhibitors, and opportunities.
- A relevant patent analysis including patents nearing expiration, and recently issued patents.
- Comprehensive profiles of major players in the field.
SCOPE OF THE STUDY
The scope of this study encompasses the global and regional markets for therapeutic and diagnostic technologies of ASD. BCC Research analyzed each market and its applications, regulatory environment, technology, market projections and market share. Issues discussed include the major drug profiles, technological features and trends. The global markets for the ASD therapeutics and diagnostics include selected markets in the U.S., Canada, the U.K., France, Germany, Spain, Italy and Japan. The markets of the rest of the world are not reported due to their economic insignificance for this report.
Ufuk Ezer. Ezer holds a bachelor's degree in bioengineering and a master's degree in biotechnology, bioprocessing and business management. He possesses extensive pharmaceutical research and development experience and has participated in projects for various international institutions and organizations. Ezer has been granted scholarships and awards during his post-study works in countries such as Japan and Panama based on the high quality of his work and excellence in the fields of research.